Accessibility Menu
 
BioLife Sciences logo

BioLife Sciences

(OTC) BLFE

Current Price$0.00
Market Cap$4,800
Since IPO (2020)-100%
5 Year-100%
1 Year+0%
1 Month+0%

BioLife Sciences Financials at a Glance

Market Cap

$4,800

Revenue (TTM)

$0.00

Net Income (TTM)

$348.49K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

170.75 (High)

Price

$0.00

Volume

370

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

BLFE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioLife Sciences

Industry

Healthcare Equipment and Supplies

Headquarters

Henderson, ON L4W 2A6, CA

BLFE Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

2%

Return on Assets

-17%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.80K

Shares Outstanding

4.83B

Volume

370

Avg. Volume

229.68K

Financials (TTM)

Gross Profit

$985.00K

Operating Income

$1.24M

EBITDA

$1.22M

Operating Cash Flow

$884.31K

Capital Expenditure

$961.00

Free Cash Flow

$885.27K

Cash & ST Invst.

$34.74K

Total Debt

$189.59K

BioLife Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2022YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$4.80K

N/A

Market Cap/Employee

$1.60K

N/A

Employees

3

N/A

Net Income

$132.05

+99.5%

EBITDA

$0.00

-100.0%

Quarterly Fundamentals

Name
Q1 2022YOY CHG

Net Cash

$382.37

+100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$10.62

-100.0%

Short Term Debt

$387.38

-100.0%

Return on Assets

-17.44%

N/A

Return on Invested Capital

1.80%

N/A

Free Cash Flow

$1.96

+100.0%

Operating Cash Flow

$1.96

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHRXPharmagen, Inc.
$0.00+0.00%
BIOAFBioasis Technologies Inc.
$0.00+0.00%
SHWZMedicine Man Technologies, Inc.
$0.00+0.00%
TOMDFTodos Medical Ltd.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About BLFE

What is the current price of BioLife Sciences?

BioLife Sciences is trading at N/A per share.

What is the 52-week range for BioLife Sciences?

Over the past 52 weeks, BioLife Sciences has traded between N/A and $0.01.

How much debt does BioLife Sciences have?

BioLife Sciences total debt is unavailable.

How much cash does BioLife Sciences have on hand?

BioLife Sciences does not have cash on hand data available.

What is BioLife Sciences’s dividend yield?

BioLife Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.